SolarBank Corp. (SUUN) Taps Data Center Veteran Jonathan Martone to Guide Data Center Market Expansion

Thumzup Media Corp. (TZUP) Continues to Boost Client Numbers, Using AI to Speed Innovation

ESGold Corp. (ESAUF) Advances Subsurface Imaging to Expand Montauban Project Potential

Torr Metals Inc. (TMET): Strategic Exploration in Established Mining Districts

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

CytRx Corporation (NASDAQ: CYTR)

November 3, 2008 at 5:46am

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company, is focused on developing high-value human therapeutics. Their drug development pipeline includes six programs in clinical development. The Company owns and operates a research and development facility in San Diego, California, and holds a 45% equity interest in RXi Pharmaceuticals (NasdaqCM: RXII ). For further information, visit the Company’s web site at www.cytrx.com.

Archives

Select A Month

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.